US OptionsDetailed Quotes
OTLK250117P10000
- 0.00
- 0.000.00%
15min DelayClose Jan 3 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover941.24%IV-346.43%PremiumJan 17, 2025Expiry Date7.76Intrinsic Value100Multiplier14DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.4569Delta0.0965Gamma0.26Leverage Ratio-0.0590Theta-0.0026Rho-0.12Eff Leverage0.0017Vega
Outlook Therapeutics Stock Discussion
Sign in to post a comment
$Outlook Therapeutics (OTLK.US)$ Reuters
1 min ago
Outlook Therapeutics Inc - First Positive Reimbursement Decision Worldwide for Lytenava™; First Launch Anticipated in H1 2025
1 min ago
Outlook Therapeutics Inc - First Positive Reimbursement Decision Worldwide for Lytenava™; First Launch Anticipated in H1 2025
6
$Outlook Therapeutics (OTLK.US)$ $3 tonight. A retest at $2.4 yesterday.
4
$Outlook Therapeutics (OTLK.US)$ 👀potential overnight play of today but I don’t like going long in red day
$Outlook Therapeutics (OTLK.US)$
this company very strong support company. until weight January you can get $5
this company very strong support company. until weight January you can get $5
2
1
$Outlook Therapeutics (OTLK.US)$ agen will be come back 5 Dollars
2
1
$Outlook Therapeutics (OTLK.US)$ Next week 2.5-3.0, holding till Jan 2025 where they will release 3 month efficacy report.
3
No comment yet
carlton griffiths OP : despite the losses